Boots moves closer to London float but billionaire Westons circle Retail With one potential suitor out of the running, high street titan Boots is moving closer to a London float, a move that would mark a return to the FTSE 100 for one of the UK’s biggest retailers and deliver a major boost to UK capital markets. The 177-year-old British pharmacy saw the withdrawal of Sigma [...]
Australian pharma giant Sigma quits Boots takeover talks Retail Australian pharmacy giant Sigma has walked away from talks over a £7.5bn private takeover of Boots, renewing hopes that the high street pharmacy could float in London. The Australian firm said on Monday that a deal with Boots would not meet its investment objectives, leaving just the billionaire Weston family in sales talks with the [...]
Boots eyes £7.5bn sale in blow to hopes of London IPO Retail The owners of Boots are weighing up a £7.5bn sale which would dash hopes of a London listing and deal another blow to the UK’s stock exchange. Sycamore Partners, the private equity firm which bought Boots’ parent company for $23.7bn last year, has been in talks with a number of suitors since before Easter. The [...]
GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn June 9, 2026 Pharma giant GSK has sealed a $10bn deal to snap up Boston-based biopharmaceutical company Nuvalent. The FTSE 100 titan said it will pay $124 per share in cash in the agreement, marking a 40 per cent premium over what Nuvalent’s stock was trading at just before this announcement. The deal is expected to officially close [...]
Hikma: FTSE 100 giant’s boss replaced by former chief after share price woes December 15, 2025 The boss of FTSE 100 giant Hikma Pharmaceuticals will be replaced by the firm’s former top chief after the group’s share price dropped by nearly a quarter this year. Riad Mishlawi has exited his role as chief executive at Hikma, with executive chairman Said Darwazah to step into the post with “immediate effect”. It ends [...]
No-zempic: Jolly Brits swap weight-loss jabs for stuffing this Christmas December 9, 2025 Brits are set to go all out this Christmas as nearly half plan to swap out their weight loss jabs for an extra helping of turkey and pudding. One in three don’t plan to return to their normal dose until after New Year in order to take full advantage of the festive season, according to [...]
GSK shares rally as chief Emma Walmsley to exit after eight years September 29, 2025 The chief executive of pharmaceutical giant GSK has announced plans to step down from the company at the end of the year. Emma Walmsley, who took the helm of the drugmaker in 2017, will be replaced by chief commercial officer Luke Miels. Miels – the former Executive Vice President of Astrazeneca – also joined the [...]
Boots: Profit jumps after closing hundreds of stores June 5, 2025 Profit at Boots has surged as the high street pharmacy chain closed hundreds of stores during its latest financial year as its owners abandoned plans for an initial public offering (IPO). The Nottingham-headquartered business shuttered 334 locations in the year to the end of August 2024, new accounts filed with Companies House have revealed. Instead [...]
GSK and Astrazeneca shares slump as Trump vows drug price cut May 12, 2025 GSK and Astrazeneca shares fall as Trump announces drug price cuts in a new executive order.
Boots warns of higher Budget costs amid sales surge January 10, 2025 High street pharmacy giant Boots has warned it faces “heightened cost pressures” in 2025 following the Autumn Budget as it revealed strong sales towards the end of last year. The new boss of the Nottingham-headquartered company, Anthony Hemmerdinger, added that while Boots has come under increased pressure, “the business is focused on navigating these and [...]